alpha-aminopyridine has been researched along with Atypical Lipomatous Tumor in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul Razak, AR; Bauer, S; Blay, JY; Clementi, G; Cubedo, R; Fabre, C; Ferretti, S; Guerreiro, N; Halilovic, E; Hütter-Krönke, ML; Italiano, A; Jullion, A; Lin, CC; Orlando, EJ; Quek, R; Sand Dejmek, J; Suarez, C | 1 |
| Boles, SG; Neel, NC; Sicklick, JK; Zare, S | 1 |
| Chen, HY; Fan, WJ; Guo, TH; Hong, DC; Liu, ZX; Niu, XH; Pan, QZ; Que, Y; Shen, LJ; Wen, XZ; Weng, DS; Xiao, W; Xu, BS; Xu, HR; Zhang, X; Zhang, XL; Zhang, YZ; Zhao, JJ; Zhou, PH | 1 |
| Konecny, GE | 1 |
1 review(s) available for alpha-aminopyridine and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
Cyclin-dependent kinase pathways as targets for women's cancer treatment.
Topics: Aminopyridines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Cycle; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Humans; Liposarcoma; Lymphoma, Mantle-Cell; Melanoma; Neoplasms, Germ Cell and Embryonal; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines; Signal Transduction | 2016 |
1 trial(s) available for alpha-aminopyridine and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Cyclin-Dependent Kinase 4; Humans; Imidazoles; Liposarcoma; Proto-Oncogene Proteins c-mdm2; Purines; Pyrimidines; Pyrroles | 2022 |
2 other study(ies) available for alpha-aminopyridine and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
Near-Complete Pathological Response to Abemaciclib in the Treatment of Well-Differentiated/Dedifferentiated Liposarcoma: A Case Report.
Topics: Aminopyridines; Benzimidazoles; Humans; Liposarcoma; Remission Induction | 2023 |
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma.
Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Benzamides; Cell Line, Tumor; Exome Sequencing; Gene Amplification; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylases; Humans; Immune Checkpoint Inhibitors; Liposarcoma; Mice; Programmed Cell Death 1 Receptor; Sequence Analysis, RNA; Xenograft Model Antitumor Assays | 2021 |